Biological Threat Detection Market Size, Share, and Industry Analysis, By Product Type (Detection Instruments, Assay Kits & Reagents, Air & Aerosol Samplers, and Others), By Technology (PCR/NAAT, Immunoassay, Sequencing/Metagenomics, Mass Spectrometry, and Others), By End-User (Government & Defense Agencies, Public Health Laboratories, Hospitals & Reference Laboratories, and Others), and Regional Forecast till 2034

The global biological threat detection market was valued at USD 4.36 billion in 2025. The market is projected to grow from USD 4.66 billion in 2026 to USD 7.98 billion by 2034, exhibiting a CAGR of 6.9% during the forecast period.

Biological threat detection systems are used to identify high-consequence pathogens, toxins, and biological agents across defense, homeland security, public health, environmental monitoring, and emergency response settings. The product demand is increasing as governments are strengthening preparedness against bioterrorism, emerging infectious diseases, and accidental or intentional biological releases. These factors are anticipated to fuel the market expansion during the forecast period.

Biological Threat Detection Market Driver

Soaring Need for Early Warning against Bioterrorism and Emerging Pathogens to Drive Market Growth

Over the past few years, the rising risk of biological incidents, emerging outbreaks, and intentional misuse of pathogens has increased the need for rapid, field-deployable, and laboratory-based detection platforms. In response, governments are investing in air monitoring, portable PCR, immunoassay-based systems, wastewater surveillance, and networked bio detection infrastructure to identify biological agents before they cause large-scale public health or security impacts. These aspects are anticipated to spur market expansion in the coming years.

• For instance, in January 2026, the U.S. Department of Homeland Security stated that the BioWatch Program operates as the nation’s only civilian biodetection system capable of providing early warning of a biological attack.

Download Free sample to learn more about this report.

The U.S. President’s FY 2026 Budget proposed approximately USD 52 million for CDC’s Biothreat Radar initiative, comprising USD 26 million each for Advanced Molecular Detection and Travel and Port Health Protection/Traveler-Based Genomic Surveillance. The funding is intended to strengthen pathogen-agnostic genomic surveillance and enable the earlier detection of emerging biological threats.

Biological Threat Detection Market Restraint

Complex Validation, False-alarm Risk, and Operational Integration Challenges to Hamper Market Growth

Biological threat detection requires high specificity, rapid sample preparation, reliable environmental sampling, validated assays, trained operators, and secure data sharing. False positives can trigger costly emergency responses, while false negatives can delay containment. Moreover, the public biodetection programs also face challenges related to technology upgrades, interagency coordination, and information-sharing requirements, which are anticipated to hamper the market growth over the forecast period.

Biological Threat Detection Market Opportunity

Portable, Multiplex, and Rapid Molecular Detection Platforms to Offer Lucrative Growth Opportunities

In the upcoming years,  the market is expected to witness significant expansion due to the increasing adoption of portable PCR, multiplex molecular assays, bioaerosol samplers, sequencing-based surveillance, and AI-enabled threat analytics. These technologies are increasingly useful for defense teams, public health laboratories, border security, and outbreak-response teams that require faster pathogen identification.

• For instance, as of June 2026, Smiths Detection’s BioFlash Biological Identifier uses CANARY technology and aerosol collection for rapid identification of common biothreat agents such as anthrax, ricin, botulinum toxin, plague, tularemia, and smallpox.

Segmentation

Key Insights

The report covers the following key insights:

• Overview of Government Initiatives for Biological Threat Detection
• Key Industry Developments - Partnerships, Mergers, Acquisitions, and Others

Analysis by Product Type

By product type, the market is segmented into detection instruments, assay kits & reagents, air & aerosol samplers, and others.

The detection instruments segment is expected to hold the largest share of the global biological threat detection market during the forecast period. Detection instruments are essential for identifying high-consequence pathogens, toxins, and biological agents in suspected samples, environmental samples, and emergency-response scenarios. The segment’s dominance is further supported by government investment in biodefense preparedness, laboratory modernization, and field-deployable detection technologies.

Analysis by Technology

By technology, the market is segmented into PCR/NAAT, immunoassay, sequencing/metagenomics, mass spectrometry, and others.

The PCR/NAAT segment is expected to hold the largest share of the global market during the forecast period. Molecular testing provides high sensitivity and specificity for pathogen confirmation and is widely used across public health and reference laboratories. As a result, key players are focused on advancing this technology for biological threat detection, which is anticipated to boost the segment growth.

Analysis By End-User

Based on end-user, the market is divided into government & defense agencies, public health laboratories, hospitals & reference laboratories, and others.

The government & defense agencies segment is expected to hold the largest share of the global market during the forecast period. The segment’s dominance is supported by government-funded biodefense programs, early warning systems, and preparedness initiatives aimed at detecting high-consequence pathogens and biological agents.

• For instance, as of June 2026, the National Biodefense Analysis and Countermeasures Center (NBACC) in the U.S. is a unique facility focused on protecting the nation from biological threats.

Regional Analysis

Request for Customization   to gain extensive market insights.

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounted for a 42.6% share of the global biological threat detection market in 2025. The growth is supported by U.S. biodefense funding, BARDA diagnostics investments, DHS BioWatch operations, and strong defense procurement.

• For instance, the President’s FY 2025 discretionary budget request for ASPR stands at USD 3.8 billion, representing an increase of USD 138.0 million compared with FY 2023 in the U.S. In addition, the budget proposes USD 20.0 billion in mandatory funding across HHS public health agencies to strengthen national biodefense capabilities, including USD 10.5 billion allocated to support ASPR activities.

Asia Pacific is expected to grow at the highest CAGR during the forecast period. The regional market growth is fueled by rising investments in public health surveillance, border health security, and emerging infectious disease preparedness, which is expected to drive the adoption of biological threat detection measures.

Key Players Covered

The global market is moderately consolidated, with competition concentrated among specialized biodefense diagnostics companies, large molecular diagnostics manufacturers, and selected government-focused technology providers.

The report includes the profiles of the following key players:

• Smiths Detection Group Ltd. (U.K.)
• BIOMÉRIEUX (France)
• Hoffmann-La Roche Ltd (Switzerland)
• Cepheid (U.S.)
• Tetracore, Inc. (U.S.)
• 908 Devices (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Bruker Corporation (U.S.)
• Bio-Rad Laboratories, Inc. (U.S.)
• Battelle (U.S.)

Key Industry Developments

• June 2026: Hoffmann-La Roche Ltd. developed an RUO PCR assay for Ebola Bundibugyo virus within six days of the genome sequence being published.
• September 2025: BioFlyte, Inc partnered with Los Alamos National Laboratory to enhance modeling and simulation tools for biothreat detection and response.